These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis. Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS. Am J Pathol; 1999 Oct; 155(4):1147-61. PubMed ID: 10514398 [Abstract] [Full Text] [Related]
63. Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis. Bail K, Notz Q, Rovituso DM, Schampel A, Wunsch M, Koeniger T, Schropp V, Bharti R, Scholz CJ, Foerstner KU, Kleinschnitz C, Kuerten S. J Neuroinflammation; 2017 Jul 24; 14(1):148. PubMed ID: 28738885 [Abstract] [Full Text] [Related]
64. The impact of single and pairwise Toll-like receptor activation on neuroinflammation and neurodegeneration. Rosenberger K, Derkow K, Dembny P, Krüger C, Schott E, Lehnardt S. J Neuroinflammation; 2014 Sep 20; 11():166. PubMed ID: 25239168 [Abstract] [Full Text] [Related]
69. The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Rawji KS, Yong VW. Clin Dev Immunol; 2013 Apr 13; 2013():948976. PubMed ID: 23840244 [Abstract] [Full Text] [Related]
78. The role of dendritic cells in CNS autoimmunity. Zozulya AL, Clarkson BD, Ortler S, Fabry Z, Wiendl H. J Mol Med (Berl); 2010 Jun 13; 88(6):535-44. PubMed ID: 20217033 [Abstract] [Full Text] [Related]
80. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. Appledorn DM, Patial S, McBride A, Godbehere S, Van Rooijen N, Parameswaran N, Amalfitano A. J Immunol; 2008 Aug 01; 181(3):2134-44. PubMed ID: 18641352 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]